H. Lundbeck AS Ordinary Shares - Class B
HLUN B: XCSE (DNK)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
DKK 96.70 | Lhgqr | Cfwspphs |
Lundbeck Earnings: Strong Sales From Strategic Brands Help Offset Generic Erosion
Lundbeck reported third-quarter results highlighted by revenue of DKK 4.95 billion. Strong performances from Lundbeck’s strategic brands Trintellix, Abilify Maintena, Rexulti, and Vyepti accounted for DKK 3.45 billion in sales, representing growth of 14% at constant exchange rates from the prior-year period. We maintain our fair value estimate of DKK 42.50 per share, and we view shares as undervalued, currently trading about 19% below our fair value estimate.